barriers to getting a glp-1 medication prescribed Breaking Barriers_Mastering the Challenges of Drug Trials GLP-1 Weight Loss Medications |

Providers will need to balance appropriate prescribing with growing consumer interest

However, oral semaglutide still provides substantial and clinically meaningful weight loss

The study looked at whether glucagon-like peptide-1 receptor agonists (GLP-1 drugs) could have benefits beyond blood sugar control

Increasing numbers of patients are taking glucagon-like peptide 1 (GLP-1) receptor agonists solely for weight loss, and many arent telling their doctors

Patients with severe symptoms, inability to maintain hydration, or significant weight loss may require hospitalization for intravenous fluids, nutritional support, and symptom management

Both medications helped most participants lose 5% or more of their body weight